Efficacy of niclosamide vs placebo in SARS-CoV-2 respiratory viral clearance, viral shedding, and duration of symptoms among patients with mild to moderate COVID …

DM Cairns, D Dulko, JK Griffiths, Y Golan… - JAMA network …, 2022 - jamanetwork.com
Importance Oral anthelmintic niclosamide has potent in vitro antiviral activity against SARS-
CoV-2. Repurposed niclosamide could be a safe and efficacious COVID-19 therapy …
被引用次数：43 相关文章

Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate …

DM Cairns, D Dulko, JK Griffiths, Y Golan… - JAMA Network …, 2022 - search.ebscohost.com
This randomized clinical trial compares the efficacy of niclosamide vs placebo in respiratory
clearance of SARS-CoV-2 among patients with mild to moderate COVID-19. Key Points …

Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms among Patients with Mild to Moderate …

DM Cairns, D Dulko, JK Griffiths, Y Golan… - JAMA network …, 2022 - cris.bgu.ac.il
Importance: Oral anthelmintic niclosamide has potent in vitro antiviral activity against SARS-
CoV-2. Repurposed niclosamide could be a safe and efficacious COVID-19 therapy …
[HTML] nih.gov

[HTML][HTML] Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to …

DM Cairns, D Dulko, JK Griffiths, Y Golan… - JAMA Network …, 2022 - ncbi.nlm.nih.gov
Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding,
and Duration of Symptoms Among Patients With Mild to Moderate COVID-19 - PMC Back to …

Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate …

DM Cairns, D Dulko, JK Griffiths, Y Golan, T Cohen… - 2022 - pubmed.ncbi.nlm.nih.gov
Importance Oral anthelmintic niclosamide has potent in vitro antiviral activity against SARS-
CoV-2. Repurposed niclosamide could be a safe and efficacious COVID-19 therapy …

Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate …

DM Cairns, D Dulko, JK Griffiths, Y Golan… - JAMA Network …, 2022 - europepmc.org
Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding,
and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 …
[PDF] academia.edu

[PDF][PDF] Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to …

DM Cairns, D Dulko, JK Griffiths, Y Golan, T Cohen… - academia.edu
Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding,
and Duration of Symptoms Among Pat Page 1 OriginalInvestigation | InfectiousDiseases Efficacy …

Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate …

DM Cairns, D Dulko, JK Griffiths, Y Golan… - JAMA Network …, 2022 - europepmc.org
Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding,
and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 …
[PDF] academia.edu

[PDF][PDF] Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to …

DM Cairns, D Dulko, JK Griffiths, Y Golan, T Cohen… - academia.edu
Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding,
and Duration of Symptoms Among Pat Page 1 OriginalInvestigation | InfectiousDiseases Efficacy …